title: Abatacept efficacy in rheumatoid arthritis is dependent upon baseline blood B-cell levels.
authors.affiliation: Service de Rhumatologie, CHRU Brest, EA 2216, INSERM ESPRI, ERI29, Université de Brest, LabEx IGO and.
authors.forename: Pierre
authors.initials: P
authors.lastname: Gazeau
authors.affiliation: Service de Rhumatologie, CHRU Brest, EA 2216, INSERM ESPRI, ERI29, Université de Brest, LabEx IGO and.
authors.forename: Valérie
authors.initials: V
authors.lastname: Devauchelle-Pensec
authors.affiliation: EA 2216, INSERM ESPRI, ERI29, Université de Brest, LabEx IGO and.
authors.forename: Pierre
authors.initials: P
authors.lastname: Pochard
authors.affiliation: EA 2216, INSERM ESPRI, ERI29, Université de Brest, LabEx IGO and.
authors.forename: Jacques-Olivier
authors.initials: JO
authors.lastname: Pers
authors.affiliation: Service de Rhumatologie, CHRU Brest, EA 2216, INSERM ESPRI, ERI29, Université de Brest, LabEx IGO and.
authors.forename: Alain
authors.initials: A
authors.lastname: Saraux
authors.affiliation: EA 2216, INSERM ESPRI, ERI29, Université de Brest, LabEx IGO and Laboratoire d'Immunologie, CHRU Brest, Brest, France.
authors.forename: Yves
authors.initials: Y
authors.lastname: Renaudineau
authors.affiliation: Service de Rhumatologie, CHRU Brest, EA 2216, INSERM ESPRI, ERI29, Université de Brest, LabEx IGO and divi.cornec@chu-brest.fr.
authors.forename: Divi
authors.initials: D
authors.lastname: Cornec
mesh_terms: D000069594:Abatacept / Q000627:therapeutic use*; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D016175:B-Lymphocyte Subsets / Q000276:immunology*; D016022:Case-Control Studies; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D018655:Lymphocyte Count; D008297:Male; D010865:Pilot Projects; D011379:Prognosis; D016896:Treatment Outcome
chemical_list: D018501:Antirheumatic Agents; D007166:Immunosuppressive Agents; D000069594:Abatacept